Developing the First Precision Medicine (Twitter)
|Title:||Developing the First Precision Medicine (Twitter)|
Learn about the NCI-funded research that enabled the first FDA approved precision medicine- the immune checkpoint inhibitor pembrolizumab.
This image is part of the NCI Annual Plan and Budget Proposal FY2019 collection.
See also http://www.cancer.gov/about-nci/budget/plan.
|Source:||National Cancer Institute (NCI)|
|Date Created:||September 12, 2017|
|Date Added:||September 12, 2017|
|Reuse Restrictions:||None - This image is in the public domain and can be freely reused. Please credit the source and, where possible, the creator listed above.|